Disposable Infusion Sets Market Size & Growth Report to 2030

The global disposable infusion sets market was valued at around USD 1 billion in 2023 and anticipated to register a significant CAGR of over 4.5% during the forecast period from 2024 to 2030. The escalating prevalence of chronic diseases, such as diabetes and cardiovascular conditions, has propelled the demand for infusion therapy, wherein disposable infusion sets play a pivotal role. With a global population increasingly aging, there’s a growing need for efficient and convenient medical interventions, with disposable infusion sets facilitating home-based healthcare trends. These sets offer notable advantages, including a reduced risk of infection and simplified usage, while continuous technological advancements enhance safety and precision.

Furthermore, the concerns over healthcare worker safety have spurred the development of needle-free infusion sets, further fostering market growth. The upsurge in surgical procedures, both in hospitals and ambulatory settings, contributes to the heightened demand for disposable infusion sets for intravenous fluid administration. Regulatory support and standards adherence, coupled with awareness initiatives, have bolstered the credibility of these sets. Notably, the global response to the COVID-19 pandemic has accentuated the critical role of infusion therapy, emphasizing the importance of reliable and safe infusion delivery systems, further propelling market growth.

Market Snapshot:

To know more about the research study, request sample papers

Market Drivers:

Rising Incidence of Chronic Diseases: The increasing prevalence of chronic diseases, including diabetes, cancer, and cardiovascular conditions, has resulted in a higher demand for infusion therapy. Disposable infusion sets are essential components in the delivery of medications and fluids, contributing to the management and treatment of these chronic conditions.

Growing Aging Population: The global population is experiencing a significant demographic shift with a growing aging population. Older individuals often require medical interventions and treatments that involve infusion therapy. Disposable infusion sets are integral to this demographic trend as they provide a convenient and efficient means of delivering necessary medications and fluids.

Home Healthcare Trend: A notable trend in healthcare is the increasing preference for home-based medical care. Disposable infusion sets play a crucial role in enabling patients to receive necessary treatments in the comfort of their homes. This trend aligns with the desire for more personalized and patient-centric healthcare experiences.

Advantages of Disposable Infusion Sets: Disposable infusion sets offer several advantages, including a reduced risk of infection, ease of use, and the elimination of the need for complex cleaning and sterilization processes. These features make disposable infusion sets an attractive choice for both healthcare providers and patients.

Technological Advancements: Ongoing advancements in infusion set technology contribute to the market’s growth. Innovations in design, materials, and features enhance the safety, precision, and user-friendliness of disposable infusion sets. These technological improvements make them more appealing to healthcare professionals and patients alike.

Prevalence of Needlestick Injuries: Concerns about healthcare worker safety and the reduction of needlestick injuries have led to the development and adoption of needle-free infusion sets. These sets provide an alternative that eliminates the risk of needlestick injuries, enhancing the safety of healthcare workers administering infusions.

Increasing Surgical Procedures: The growing number of surgical procedures, both in hospital settings and ambulatory surgical centers, drives the demand for disposable infusion sets. These sets are commonly used for intravenous fluid administration during and after surgeries, contributing to patient care and recovery.

Regulatory Support and Standards: Adherence to regulatory standards and approvals from health authorities, such as the FDA, is crucial for the market. Compliance with these standards enhances the credibility and trustworthiness of disposable infusion sets, ensuring their safety and efficacy in clinical use.

Market Insights:

Market Analysis by Material:

The global disposable infusion sets market is bifurcated into material, age group, end-user, and geography. On the basis of material, the market is further segmented into polyvinyl chloride (PVC), polyolefins, nitroglycerin, and others. Polyvinyl chloride (PVC) stands as the dominant material in the disposable infusion sets market segment. PVC’s widespread adoption is attributed to its ergonomic features, including transparency, strong resistance to sterilization, ease of sealing, high tensile strength, and cost-effectiveness in manufacturing. The addition of plasticizers like polyethylene and DEHP enhances PVC’s flexibility. Looking ahead, it is anticipated that polyolefin will witness substantial market growth due to its improved biocompatibility and non-reactivity with drug particles administered intravenously. This shift suggests a potential trend towards alternative materials that address concerns related to health and compatibility, signaling a dynamic landscape in the disposable infusion sets market.

Polyvinyl Chloride (PVC): PVC is a common material used in disposable infusion sets. It is known for its flexibility, transparency, and cost-effectiveness, making it suitable for a wide range of medical applications. PVC infusion sets are lightweight, easy to handle, and have good chemical resistance. However, concerns have been raised about the potential release of phthalates, particularly DEHP, during the use of PVC medical devices.

Polyolefins: Polyolefins, such as polyethylene and polypropylene, are used in the manufacturing of disposable infusion sets. These materials offer good chemical resistance and are often chosen for their biocompatibility. Polyolefin infusion sets may be considered as alternatives to PVC, addressing concerns related to phthalate exposure. They are known for their durability and stability.

Nitroglycerin: Nitroglycerin, a chemical compound, is sometimes mentioned in the context of infusion therapy, particularly in the treatment of certain medical conditions like angina. However, it’s important to note that nitroglycerin is a medication, not a material used in the construction of infusion sets. Nitroglycerin is typically administered through specialized delivery systems, but the primary focus here is likely to be on the medical application rather than the material composition.

Others: The category “Others” may encompass various materials depending on specific product formulations and advancements in the industry. This could include materials such as ethylene-vinyl acetate (EVA), thermoplastic elastomers (TPE), and other polymer blends. These alternative materials are often chosen to address specific requirements, such as improved flexibility, reduced environmental impact, or enhanced compatibility with certain medications.

Market Analysis by End-User:

On the basis of end-user, the global disposable infusion sets market is further segmented into hospital & clinics, ambulatory surgical centers, and others. Hospitals and clinics dominate the end-user segment, holding the largest market share in the disposable infusion sets market. The market growth is primarily propelled by a substantial increase in the number of surgical procedures and a continuous rise in cases of microbial infections necessitating intravenous drug infusion. Additionally, ambulatory surgical centers are anticipated to experience robust market growth in the coming years. This is attributed to the escalating support provided by government healthcare agencies, aiming to establish ambulatory surgical centers that offer emergency medical assistance to trauma patients, especially in remote locations and along highways. This expected growth underscores the evolving landscape of healthcare delivery, with an emphasis on accessible and timely medical interventions.

Hospitals & Clinics: Hospitals and clinics represent a major end-user segment for disposable infusion sets. These healthcare institutions widely use infusion therapy for various medical treatments and procedures. Disposable infusion sets are integral in hospital settings for intravenous administration of fluids, medications, and other therapeutic agents. They are employed across various departments, including emergency rooms, intensive care units, and general wards.

Ambulatory Surgical Centers: Ambulatory Surgical Centers (ASCs) are facilities that provide outpatient surgical procedures, and they have gained prominence for their cost-effectiveness and efficiency. Disposable infusion sets find application in ASCs during outpatient surgeries and post-operative care. They are used for intravenous fluid administration, ensuring patients receive necessary fluids and medications in a controlled and sterile environment.

Others: The category “Others” typically includes alternative healthcare settings and specialized facilities beyond hospitals, clinics, and ambulatory surgical centers. In this segment, disposable infusion sets may be used in settings such as long-term care facilities, nursing homes, and home healthcare. They cater to specific healthcare needs outside the traditional hospital and clinic settings.

The disposable infusion sets market research report presents the analysis of each segment from 2020 to 2030 considering 2023 as the base year for the research. The compounded annual growth rate (CAGR) for each respective segment is calculated for the forecast period from 2024 to 2030.

Historical & Forecast Period

• 2020-22 – Historical Year
• 2023 – Base Year
• 2024-2030 – Forecast Period

Market Segmentation:

By Material:

• Polyvinyl Chloride (PVC)
• Polyolefins
• Nitroglycerin
• Others

By Age Group:

• Adult Infusion Sets
• Pediatric Infusion Sets

By End-User:

• Hospital & Clinics
• Ambulatory Surgical Centers
• Others

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Regional Analysis:

Currently, North America is at the forefront of the disposable infusion sets market geography segment. The key driver of market growth in the region is the increasing prevalence of cancer patients undergoing chemotherapy administered through disposable infusion sets. According to recent data from the American Cancer Society (ACS), around 1,762,450 new cancer cases were reported in 2019, with approximately 85% of these patients undergoing chemotherapy. The robust market growth in North America is further supported by a favorable regulatory environment, exemplified by the proactive approach of the US Food and Drug Administration (USFDA) in expediting the CE certification process for disposable infusion sets. This regulatory support enhances market dynamics and contributes to the region’s leading position in the disposable infusion sets market.

The United States and Canada, key contributors to the North American market, possess advanced healthcare infrastructure, high healthcare expenditure, and a well-established regulatory framework. These factors collectively contribute to the region’s significant market share in the disposable infusion sets segment. The prevalence of chronic diseases, coupled with a proactive approach toward healthcare management, drives the demand for infusion therapy, making disposable infusion sets a crucial component of medical interventions in North America. The region’s emphasis on patient care, technological advancements, and a growing aging population further solidify its dominance in the disposable infusion sets market.

North America’s dominance is also underscored by its effective response to global health crises, such as the COVID-19 pandemic. The region’s ability to swiftly adapt to changing healthcare needs, coupled with a strong commitment to medical innovation, positions it as a leader in the disposable infusion sets market. As healthcare standards continue to evolve and demand for advanced medical devices grows, North America is likely to maintain its dominance, supported by a combination of sophisticated healthcare systems, substantial investments, and a proactive approach to addressing healthcare challenges.

Competitive Assessment:

Some of the prominent market players operating in the global disposable infusion sets market are LILY MEDICAL CORPORATION, Baxter AG, Fresenius Kabi Ltd., Nipro Corporation, and Vygon SA. Companies are exploring markets by expansion, new investment, the introduction of new services, and collaboration as their preferred strategies. Players are exploring new geography through expansion and acquisition to gain a competitive advantage through joint synergy.

Key Companies:

• LILY MEDICAL CORPORATION
• Baxter AG
• Fresenius Kabi Ltd.
• Nipro Corporation
• Vygon SA
• Smiths Medical
• Becton Dickinson & Company
• Bıçakcılar
• Terumo Medical Corporation
• Rays S.P.A.

Key Questions Answered by Disposable Infusion Sets Market Report

• Global disposable infusion sets market forecasts from 2024-2030
• Regional market forecasts from 2024-2030 covering Asia-Pacific, North America, Europe, Middle East & Africa, and Latin America
• Country-level forecasts from 2024-2030 covering 15 major countries from the regions as mentioned above
• Disposable infusion sets submarket forecasts from 2024-2030 covering the market by material, age group, end-user, and geography
• Various industry models such as SWOT analysis, Value Chain Analysis about the market
• Analysis of the key factors driving and restraining the growth of the global, regional, and country-level disposable infusion sets markets from 2024-2030
• Competitive Landscape and market positioning of top 10 players operating in the market